ABIOMED INC (ABMD) Stock News

NASDAQ:ABMD - Nasdaq - US0036541003 - Common Stock - Currency: USD

381.02 +0.23 (+0.06%)

After market: 381.3 +0.28 (+0.07%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ABMD Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: The Motley Fool - Mentions: JNJ

Is It Too Late to Buy Johnson & Johnson's Stock?

3 years ago - By: The Motley Fool - Mentions: AMZN KO JNJ

2 Best Buffett Stocks to Buy for the Long Haul

3 years ago - By: Seeking Alpha - Mentions: JNJ

JNJ stock dips as it closes Abiomed acquisition (NYSE:JNJ)

3 years ago - By: Abiomed, Inc.

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

3 years ago - By: Benzinga - Mentions: NVO NVS PFE HZNP

Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look?

3 years ago - By: Benzinga

News Image

If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today

3 years ago - By: Investor's Business Daily - Mentions: JNJ HZNP AMGN SNY

Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi

3 years ago - By: Abiomed, Inc.

First Patients in the World Treated with Impella RP Flex with SmartAssist

3 years ago - By: Kahn Swick & Foti, LLC

ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD